Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stem Cell Research

  Free Subscription

Articles published in
Bone Marrow Transplant
    September 2022
  1. QIAO X, Bilinski J, Wang L, Yang T, et al
    Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease.
    Bone Marrow Transplant. 2022 Sep 27. pii: 10.1038/s41409-022-01824.
    >> Share

  2. JUNG SH, Min CK, Lee JH, Mun YC, et al
    Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909).
    Bone Marrow Transplant. 2022 Sep 22. pii: 10.1038/s41409-022-01818.
    >> Share

  3. BARANWAL A, Mangaonkar A, Shah MV, Litzow MR, et al
    High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant.
    Bone Marrow Transplant. 2022 Sep 21. pii: 10.1038/s41409-022-01829.
    >> Share

  4. MULAS O, Caocci G, Efficace F, Piras E, et al
    Long-term health-related quality of life in patients with beta-thalassemia after unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Sep 16. pii: 10.1038/s41409-022-01823.
    >> Share

  5. PIZZOLA CJ, Cioccio J, Rakszawski KL, Nickolich M, et al
    Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities.
    Bone Marrow Transplant. 2022 Sep 12. pii: 10.1038/s41409-022-01821.
    >> Share

  6. ATSUTA Y, Sugita J, Nakamae H, Maruyama Y, et al
    Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2022 Sep 12. pii: 10.1038/s41409-022-01822.
    >> Share

  7. KUANG P, Lin T, Chen X, Yang Y, et al
    Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells.
    Bone Marrow Transplant. 2022 Sep 8. pii: 10.1038/s41409-022-01789.
    >> Share

  8. SPYRIDONIDIS A, Labopin M, Brissot E, Moiseev I, et al
    Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT.
    Bone Marrow Transplant. 2022 Sep 7. pii: 10.1038/s41409-022-01816.
    >> Share

  9. TANG B, Cai Z, Wang Z, Lin D, et al
    Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2022 Sep 2. pii: 10.1038/s41409-022-01797.
    >> Share

  10. PECI F, Dekker L, Pagliaro A, van Boxtel R, et al
    The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2022;57:1357-1364.
    >> Share

    August 2022
  11. QI HZ, Xu J, Yang QQ, Lin R, et al
    Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission.
    Bone Marrow Transplant. 2022 Aug 30. pii: 10.1038/s41409-022-01796.
    >> Share

  12. FILE B, Gergis M, Gergis U
    The effect of hematopoietic stem cell transplantation on fertility and strategies for improvement.
    Bone Marrow Transplant. 2022 Aug 29. pii: 10.1038/s41409-022-01792.
    >> Share

  13. ELLIOTT J, Ahlawat S, Prince HM, Kennedy G, et al
    Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides.
    Bone Marrow Transplant. 2022 Aug 26. pii: 10.1038/s41409-022-01787.
    >> Share

  14. SILBERT S, Cole K, Bedoya SZ, Freeman AF, et al
    Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency.
    Bone Marrow Transplant. 2022 Aug 23. pii: 10.1038/s41409-022-01778.
    >> Share

  15. JACOBSEN ED, Kim HT, Jeter E, Jacobson C, et al
    Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2022 Aug 22. pii: 10.1038/s41409-022-01784.
    >> Share

  16. NAGLER A, Tsirigotis P
    Donor lymphocyte infusion (DLI) post haploidentical stem cell transplantation (Haplo) with post-transplant cyclophosphamide (PTCy): crossing the human leukocyte antigen (HLA) barrier.
    Bone Marrow Transplant. 2022 Aug 22. pii: 10.1038/s41409-022-01785.
    >> Share

  17. SUGITA J, Atsuta Y, Nakamae H, Maruyama Y, et al
    Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation.
    Bone Marrow Transplant. 2022 Aug 20. pii: 10.1038/s41409-022-01770.
    >> Share

  18. BI X, Gergis U, Wagner JL, Carabasi M, et al
    Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies.
    Bone Marrow Transplant. 2022 Aug 19. pii: 10.1038/s41409-022-01780.
    >> Share

  19. YUAN Y, Wong P, Butler JP, Henden A, et al
    High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation.
    Bone Marrow Transplant. 2022 Aug 15. pii: 10.1038/s41409-022-01773.
    >> Share

  20. BARANWAL A, Byun J, Ritz E, Kadanagowd A, et al
    Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2022 Aug 15. pii: 10.1038/s41409-022-01779.
    >> Share

  21. HANNA P, Strohbehn I, Moreno D, Harden D, et al
    Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma.
    Bone Marrow Transplant. 2022 Aug 3. pii: 10.1038/s41409-022-01767.
    >> Share

  22. KANG KR, Kim YJ, Ahn MB, Kang HM, et al
    Shorter duration of protection and lower geometric mean titers against A/H3N2 antigen of the quadrivalent influenza vaccine in children post-allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Aug 1. pii: 10.1038/s41409-022-01768.
    >> Share

    July 2022
  23. MA J, Sun S, Hu Y, Wu M, et al
    Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL.
    Bone Marrow Transplant. 2022 Jul 25. pii: 10.1038/s41409-022-01766.
    >> Share

  24. PRABAHRAN A, Koldej R, Chee L, Szer J, et al
    Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review.
    Bone Marrow Transplant. 2022 Jul 23. pii: 10.1038/s41409-022-01761.
    >> Share

  25. BUSCA A, Gabrielli G, Sidoti F, Costa C, et al
    SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor.
    Bone Marrow Transplant. 2022 Jul 16. pii: 10.1038/s41409-022-01763.
    >> Share

  26. ZU Y, Li Z, Gui R, Liu Y, et al
    Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre,
    Bone Marrow Transplant. 2022 Jul 15. pii: 10.1038/s41409-022-01754.
    >> Share

  27. DE KLOET LC, Bense JE, van der Stoep MYEC, Louwerens M, et al
    Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases.
    Bone Marrow Transplant. 2022 Jul 15. pii: 10.1038/s41409-022-01755.
    >> Share

  28. MERLI P, Massa M, Russo A, Rea F, et al
    Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient.
    Bone Marrow Transplant. 2022 Jul 14. pii: 10.1038/s41409-022-01752.
    >> Share

  29. MASSOUD R, Klyuchnikov E, Gagelmann N, Zabelina T, et al
    Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2022 Jul 13. pii: 10.1038/s41409-022-01666.
    >> Share

  30. JAMY O, Arora S, Meredith R, Salzman D, et al
    Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.
    Bone Marrow Transplant. 2022 Jul 9. pii: 10.1038/s41409-022-01757.
    >> Share

  31. TSAMADOU C, Gowdavally S, Platzbecker U, Sala E, et al
    Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01751.
    >> Share

  32. JACOBS JW, Adkins BD, Wheeler AP, Booth GS, et al
    Diversity, equity, and inclusion in transfusion medicine, blood donation, and blood and bone marrow transplantation: language matters.
    Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01758.
    >> Share

  33. HASHMI S, Ram R
    The great Lazar-a Graft-versus-host-disease patient!
    Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01707.
    >> Share

  34. RANGARAJAN HG, Crowell SA, Towerman AS, Shenoy SS, et al
    CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.
    Bone Marrow Transplant. 2022 Jul 7. pii: 10.1038/s41409-022-01749.
    >> Share

  35. MARCAIS A, Mahlaoui N, Neven B, Lanternier F, et al
    Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency.
    Bone Marrow Transplant. 2022 Jul 6. pii: 10.1038/s41409-022-01739.
    >> Share

  36. YINGLING SK, Gonzalez RM, Dillaman M, Seago K, et al
    Impact of body mass index (BMI) on the efficacy of plerixafor for hematopoietic progenitor cell (HPC) mobilization.
    Bone Marrow Transplant. 2022;57:1194-1197.
    >> Share

  37. DING L, Han DM, Yan HM, Zhou JX, et al
    Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients.
    Bone Marrow Transplant. 2022;57:1086-1094.
    >> Share

    June 2022
  38. NAGLER A, Labopin M, Cornelissen JJ, Forcade E, et al
    Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Socie
    Bone Marrow Transplant. 2022 Jun 30. pii: 10.1038/s41409-022-01742.
    >> Share

  39. LE BRIS Y, Costes D, Bourgade R, Guillaume T, et al
    Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies.
    Bone Marrow Transplant. 2022 Jun 28. pii: 10.1038/s41409-022-01747.
    >> Share

  40. SELVARAJAN S, Tammiraju S, Lionel S, Kulkarni U, et al
    Cyclophosphamide induced haemorrhagic myocarditis-pericarditis: a rare but lethal complication in the setting of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jun 27. pii: 10.1038/s41409-022-01745.
    >> Share

  41. LEMAIRE B, Combescure C, Chalandon Y, Vuilleumier N, et al
    Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jun 25. pii: 10.1038/s41409-022-01737.
    >> Share

  42. HOLTAN SG, Yu J, Paranagama D, Tang J, et al
    Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study.
    Bone Marrow Transplant. 2022 Jun 23. pii: 10.1038/s41409-022-01736.
    >> Share

  43. TANG L, Wu Y, Lei R, Liu J, et al
    Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes.
    Bone Marrow Transplant. 2022 Jun 22. pii: 10.1038/s41409-022-01729.
    >> Share

  44. PEROVIC V, Sabol I, Grce M, Inngjerdingen M, et al
    Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network.
    Bone Marrow Transplant. 2022 Jun 11. pii: 10.1038/s41409-022-01733.
    >> Share

  45. LAZZARI L, Balaguer-Rosello A, Montoro J, Greco R, et al
    Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia.
    Bone Marrow Transplant. 2022 Jun 9. pii: 10.1038/s41409-022-01725.
    >> Share

  46. SONG Y, Chen S, Roseman J, Scigliano E, et al
    Patient-generated strategies for strengthening adherence to multiple medication regimens after allogeneic stem cell transplantation: a qualitative study.
    Bone Marrow Transplant. 2022 Jun 9. pii: 10.1038/s41409-022-01727.
    >> Share

  47. LIU Y, Duan Z, Li F, Zhang X, et al
    Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention.
    Bone Marrow Transplant. 2022 Jun 7. pii: 10.1038/s41409-022-01731.
    >> Share

  48. ELHADAD S, Chadburn A, Magro C, Van Besien K, et al
    C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Bone Marrow Transplant. 2022 Jun 4. pii: 10.1038/s41409-022-01723.
    >> Share

  49. TAMAKI M, Matsumi S, Nakasone H, Nakamura Y, et al
    Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jun 4. pii: 10.1038/s41409-022-01730.
    >> Share

  50. HANNA P, Strohbehn I, Wang Q, Frigault M, et al
    Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2022 Jun 4. pii: 10.1038/s41409-022-01720.
    >> Share

  51. RUESCH M, Amar El Dusouqui S, Buhrfeind E, Buser A, et al
    Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors.
    Bone Marrow Transplant. 2022;57:918-924.
    >> Share

    May 2022
  52. PESSOA JM, da Rosa EL, Americo AD, Motta CL, et al
    Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study.
    Bone Marrow Transplant. 2022 May 30. pii: 10.1038/s41409-022-01718.
    >> Share

  53. WELLS JR, Kang G, Suliman AY, Li Y, et al
    Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children.
    Bone Marrow Transplant. 2022 May 28. pii: 10.1038/s41409-022-01726.
    >> Share

  54. NISHIDA M, Sugita J, Iwai T, Sato M, et al
    Ultrasonographic scoring system of late-onset sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 May 25. pii: 10.1038/s41409-022-01717.
    >> Share

  55. FERNANDEZ-SOJO J, Cid J, Azqueta C, Valdivia E, et al
    Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2022 May 25. pii: 10.1038/s41409-022-01722.
    >> Share

  56. ANDERSSON BS, Thall PF, Ma J, Valdez BC, et al
    A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan +/- clofarabine in allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2022 May 24. pii: 10.1038/s41409-022-01705.
    >> Share

  57. LINGBLOM C, Andersson K, Johansson JE, Wenneras C, et al
    Multivariate modeling of eosinophil markers and other cellular immune parameters associated with the development of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2022 May 23. pii: 10.1038/s41409-022-01708.
    >> Share

  58. ANGELOV D, Dillon J, Mellerick L, Pender E, et al
    Allogeneic transplantation in Cutaneous T-cell Lymphoma: improved outcomes associated with early transplantation and acute graft versus host disease.
    Bone Marrow Transplant. 2022 May 20. pii: 10.1038/s41409-022-01713.
    >> Share

  59. AMONOO HL, Harnedy LE, Deary EC, Traeger L, et al
    Peer support in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): a qualitative study.
    Bone Marrow Transplant. 2022 May 19. pii: 10.1038/s41409-022-01711.
    >> Share

  60. ALEXANDER T, Greco R
    Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Bone Marrow Transplant. 2022 May 16. pii: 10.1038/s41409-022-01702.
    >> Share

  61. KUSKONMAZ B, Ayvaz D, Okur FV, Aydin B, et al
    First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up.
    Bone Marrow Transplant. 2022 May 14. pii: 10.1038/s41409-022-01704.
    >> Share

  62. DANYLESKO I, Peczynski C, Labopin M, Polge E, et al
    Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT.
    Bone Marrow Transplant. 2022 May 13. pii: 10.1038/s41409-022-01695.
    >> Share

  63. FRIETSCH JJ, Miethke J, Linke P, Crodel CC, et al
    Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma.
    Bone Marrow Transplant. 2022 May 10. pii: 10.1038/s41409-022-01701.
    >> Share

  64. PENGLASE R, Englert H, Tymms K, Carr A, et al
    Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning-do we need 200 mg/kg cyclophosphamide?
    Bone Marrow Transplant. 2022 May 6. pii: 10.1038/s41409-022-01696.
    >> Share

  65. WIECZOREK M, Mariotto S, Ferrari S, Mosna F, et al
    Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series.
    Bone Marrow Transplant. 2022 May 5. pii: 10.1038/s41409-022-01690.
    >> Share

  66. OHASHI T, Aoki J, Ando T, Ishiyama Y, et al
    Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
    Bone Marrow Transplant. 2022 May 3. pii: 10.1038/s41409-022-01678.
    >> Share

  67. WADA F, Kondo T, Yamamoto R, Yamagiwa T, et al
    Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2022 May 2. pii: 10.1038/s41409-022-01692.
    >> Share

    April 2022
  68. AL SALEH AS, Alghamdi AI, Alzahrani M, Alahmari B, et al
    Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis.
    Bone Marrow Transplant. 2022 Apr 30. pii: 10.1038/s41409-022-01694.
    >> Share

  69. LIANG H, Pan L, Xie Y, Fan J, et al
    Health-related quality of life in pediatric patients with beta-thalassemia major after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Apr 29. pii: 10.1038/s41409-022-01663.
    >> Share

  70. NAWAS MT, Lee JO, Flynn J, Maloy M, et al
    CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis.
    Bone Marrow Transplant. 2022 Apr 28. pii: 10.1038/s41409-022-01684.
    >> Share

  71. SOLA M, Bhatt V, Palazzo M, Cavalier KE, et al
    Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant.
    Bone Marrow Transplant. 2022 Apr 27. pii: 10.1038/s41409-022-01689.
    >> Share

  72. ZHANG R, Lu X, Tang LV, Wang HF, et al
    Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Apr 22. pii: 10.1038/s41409-022-01645.
    >> Share

  73. NIEDERWIESER C, Weber B, Reichard M, Gagelmann N, et al
    Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19.
    Bone Marrow Transplant. 2022 Apr 20. pii: 10.1038/s41409-022-01660.
    >> Share

  74. DELIA M, Carluccio P, Gagliardi VP, Mestice A, et al
    Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a prospective, multicenter study in patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2022 Apr 19. pii: 10.1038/s41409-022-01676.
    >> Share

  75. SALHOTRA A, Talley M, Wu X, Tsai W, et al
    Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host disease.
    Bone Marrow Transplant. 2022 Apr 19. pii: 10.1038/s41409-022-01671.
    >> Share

  76. SCHROEDER MA, Hari PN, Blithe A, Paranagama D, et al
    Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program.
    Bone Marrow Transplant. 2022 Apr 18. pii: 10.1038/s41409-022-01673.
    >> Share

  77. SCHENONE L, Houillier C, Tanguy ML, Choquet S, et al
    Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
    Bone Marrow Transplant. 2022 Apr 14. pii: 10.1038/s41409-022-01648.
    >> Share

  78. LAZANA I, Floro L, Christmas T, Shah S, et al
    Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option.
    Bone Marrow Transplant. 2022 Apr 12. pii: 10.1038/s41409-022-01657.
    >> Share

  79. MASOOD A, Wahab A, Iqbal Q, Davis J, et al
    Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature.
    Bone Marrow Transplant. 2022 Apr 11. pii: 10.1038/s41409-022-01668.
    >> Share

  80. SHIPTON MJ, Kinsella PM, Davis T, Azzato F, et al
    Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant.
    Bone Marrow Transplant. 2022 Apr 11. pii: 10.1038/s41409-022-01669.
    >> Share

  81. JORIS MM, Schmidt AH, Bernas SN, Feinberg J, et al
    Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor Association.
    Bone Marrow Transplant. 2022 Apr 9. pii: 10.1038/s41409-022-01667.
    >> Share

  82. PIEVANI A, Granata V, Desantis G, Antolini L, et al
    CD14 positive cells accelerate hematopoietic stem cell engraftment.
    Bone Marrow Transplant. 2022 Apr 8. pii: 10.1038/s41409-022-01662.
    >> Share

  83. LIU H, Liu W, Li R, Jiao Y, et al
    A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma.
    Bone Marrow Transplant. 2022 Apr 7. pii: 10.1038/s41409-022-01655.
    >> Share

  84. COOK J, Gonsalves WI, Gertz MA, Visram A, et al
    Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosis.
    Bone Marrow Transplant. 2022 Apr 2. pii: 10.1038/s41409-022-01659.
    >> Share

  85. MCCANN SR
    Choices: peripheral blood or marrow: natural or cloned yeasts.
    Bone Marrow Transplant. 2022;57:524-525.
    >> Share

    March 2022
  86. JANSSEN MJM, Bruns AHW, Verduyn Lunel FM, Raijmakers RAP, et al
    Correction to: Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2022 Mar 31. pii: 10.1038/s41409-022-01651.
    >> Share

  87. SCHNEIDEWIND L, Neumann T, Peters N, Kranz J, et al
    Significance of men's health in long-term survivors of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2022 Mar 25. pii: 10.1038/s41409-022-01638.
    >> Share

  88. MACHOWICZ R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, et al
    Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT.
    Bone Marrow Transplant. 2022 Mar 24. pii: 10.1038/s41409-022-01634.
    >> Share

  89. JIANG JL, Chen M, Wang LN, Wan M, et al
    Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study.
    Bone Marrow Transplant. 2022 Mar 24. pii: 10.1038/s41409-022-01643.
    >> Share

  90. ANDRE I, Simons L, Ma K, Moirangthem RD, et al
    Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
    Bone Marrow Transplant. 2022 Mar 16. pii: 10.1038/s41409-022-01629.
    >> Share

  91. KARAM D, Gertz M, Lacy M, Dispenzieri A, et al
    Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplant.
    Bone Marrow Transplant. 2022 Mar 16. pii: 10.1038/s41409-022-01631.
    >> Share

  92. UENO T, Ohta T, Sugio Y, Ohno Y, et al
    Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Mar 10. pii: 10.1038/s41409-022-01633.
    >> Share

  93. GALLI E, Sora F, Hohaus S, Bellesi S, et al
    Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma.
    Bone Marrow Transplant. 2022 Mar 8. pii: 10.1038/s41409-022-01632.
    >> Share

  94. PAHNKE S, Nygell UA, Johansson JE, Kisch A, et al
    Cancer incidence in healthy Swedish peripheral blood stem cell donors.
    Bone Marrow Transplant. 2022 Mar 7. pii: 10.1038/s41409-022-01617.
    >> Share

  95. EL JURDI N, Okoev G, DeFor TE, Holtan SG, et al
    Predictors and outcomes of flares in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2022 Mar 5. pii: 10.1038/s41409-022-01628.
    >> Share

    February 2022
  96. ZHANG Z, Hasegawa Y, Hashimoto D, Senjo H, et al
    Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Feb 28. pii: 10.1038/s41409-022-01619.
    >> Share

  97. FORCADE E, Chevret S, Finke J, Ehninger G, et al
    Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT.
    Bone Marrow Transplant. 2022 Feb 26. pii: 10.1038/s41409-022-01620.
    >> Share

  98. YESILIPEK MA, Uygun V, Kupesiz A, Karasu G, et al
    Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience.
    Bone Marrow Transplant. 2022 Feb 24. pii: 10.1038/s41409-022-01613.
    >> Share

  99. LINDAHL H, Vonlanthen S, Valentini D, Bjorklund AT, et al
    Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Bone Marrow Transplant. 2022 Feb 24. pii: 10.1038/s41409-022-01615.
    >> Share

  100. ARSLAN S, Ali H, Mei M, Marcucci G, et al
    Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.
    Bone Marrow Transplant. 2022 Feb 22. pii: 10.1038/s41409-022-01590.
    >> Share

  101. HUTT D, Arjona ET, Mekelenkamp H, Galimard JE, et al
    Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians.
    Bone Marrow Transplant. 2022 Feb 21. pii: 10.1038/s41409-021-01559.
    >> Share

  102. MADANCHI R, Engel NW, Alsdorf W, Oing C, et al
    Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients.
    Bone Marrow Transplant. 2022 Feb 21. pii: 10.1038/s41409-022-01614.
    >> Share

  103. MORENO-CASTANO AB, Palomo M, Torramade-Moix S, Martinez-Sanchez J, et al
    An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous Hct.
    Bone Marrow Transplant. 2022 Feb 18. pii: 10.1038/s41409-022-01610.
    >> Share

  104. LEIMI L, Jahnukainen K, Olkinuora H, Meri S, et al
    Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Feb 17. pii: 10.1038/s41409-022-01607.
    >> Share

  105. YOON SE, Jo H, Kang ES, Cho D, et al
    Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis.
    Bone Marrow Transplant. 2022 Feb 16. pii: 10.1038/s41409-022-01605.
    >> Share

  106. DROZDOV D, Petermann K, Dougoud S, Oberholzer S, et al
    Dynamics of recent thymic emigrants in pediatric recipients of allogeneic hematopoetic stem cell transplantation.
    Bone Marrow Transplant. 2022 Feb 9. pii: 10.1038/s41409-022-01594.
    >> Share

  107. SUH JK, Im HJ, Kang SH, Kim H, et al
    Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.
    Bone Marrow Transplant. 2022 Feb 7. pii: 10.1038/s41409-021-01556.
    >> Share

  108. PIEMONTESE S, Lazzari L, Ruggeri A, Marcatti M, et al
    Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience.
    Bone Marrow Transplant. 2022 Feb 5. pii: 10.1038/s41409-022-01600.
    >> Share

  109. GEVORGIAN AG, Kozlov AV, Tolkunova PS, Kazantzev IV, et al
    Tandem autologous hematopoietic stem cell transplantation for embryonal brain tumors in infants and very young children.
    Bone Marrow Transplant. 2022 Feb 3. pii: 10.1038/s41409-022-01593.
    >> Share

  110. PARSONS SK, Rodday AM, Weidner RA, Morris E, et al
    Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant.
    Bone Marrow Transplant. 2022 Feb 2. pii: 10.1038/s41409-022-01584.
    >> Share

  111. LINDHOLM C, Olofsson E, Creignou M, Nilsson L, et al
    Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study.
    Bone Marrow Transplant. 2022 Feb 2. pii: 10.1038/s41409-022-01582.
    >> Share

  112. FRIEND BD, Muhsen IN, Patel S, Hill LC, et al
    Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.
    Bone Marrow Transplant. 2022 Feb 1. pii: 10.1038/s41409-022-01599.
    >> Share

  113. NAGLER A, Labopin M, Huang XJ, Blaise D, et al
    Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT.
    Bone Marrow Transplant. 2022 Feb 1. pii: 10.1038/s41409-021-01537.
    >> Share

    January 2022
  114. FILE B, Huang Y, Peedin A, Gergis U, et al
    The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies.
    Bone Marrow Transplant. 2022 Jan 26. pii: 10.1038/s41409-022-01578.
    >> Share

  115. SKEENS M, Guttoo P, Stanek JR, Taylor K, et al
    An Exploration of COVID-19 Impact and Vaccine Hesitancy in Parents of Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients.
    Bone Marrow Transplant. 2022 Jan 24. pii: 10.1038/s41409-022-01587.
    >> Share

  116. NI F, Yin ETS, Zhou L, Zhao H, et al
    Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion.
    Bone Marrow Transplant. 2022 Jan 24. pii: 10.1038/s41409-021-01554.
    >> Share

  117. UTSUNOMIYA A, Tokunaga M, Nakano N, Fujiwara H, et al
    Long-term follow-up of patients with ATL after autologous stem cell transplantation.
    Bone Marrow Transplant. 2022 Jan 23. pii: 10.1038/s41409-021-01412.
    >> Share

  118. KAWAJIRI A, Kawase T, Tanaka H, Fukuda T, et al
    Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation.
    Bone Marrow Transplant. 2022 Jan 21. pii: 10.1038/s41409-021-01552.
    >> Share

  119. MANNINA D, Badbaran A, Wolschke C, Klyuchnikov E, et al
    Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis.
    Bone Marrow Transplant. 2022 Jan 19. pii: 10.1038/s41409-022-01566.
    >> Share

  120. JEPPESEN H, Kielsen K, Siersma V, Lindegaard J, et al
    Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors.
    Bone Marrow Transplant. 2022 Jan 18. pii: 10.1038/s41409-022-01564.
    >> Share

  121. HASHMI H, Shockley A, Davis JA
    'Save the day with a Stem Cell Rescue': Use of autologous hematopoietic stem cell boost for hematopoietic recovery after CAR T cell therapy.
    Bone Marrow Transplant. 2022 Jan 17. pii: 10.1038/s41409-022-01570.
    >> Share

  122. SHAO DF, Li JH, Hu T, Zhang ZX, et al
    Clinical outcomes of individualized busulfan-dosing in hematopoietic stem cell transplantation in Chinese children undergoing with therapeutic drug monitoring.
    Bone Marrow Transplant. 2022 Jan 17. pii: 10.1038/s41409-021-01545.
    >> Share

  123. SHIMONI A
    Relapse of acute leukemia after a second allogeneic stem- cell transplantation; Is there any hope for cure?
    Bone Marrow Transplant. 2022 Jan 14. pii: 10.1038/s41409-021-01508.
    >> Share

  124. SOERENSEN JF, Aggerholm A, Rosenberg CA, Bill M, et al
    Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
    Bone Marrow Transplant. 2022 Jan 13. pii: 10.1038/s41409-022-01567.
    >> Share

  125. SHIMONI A, Labopin M, Angelucci E, Blaise D, et al
    The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML.
    Bone Marrow Transplant. 2022 Jan 13. pii: 10.1038/s41409-021-01493.
    >> Share

  126. TRUNK AD, Shewan SK, Lee CJ, Parker CJ, et al
    Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination.
    Bone Marrow Transplant. 2022 Jan 11. pii: 10.1038/s41409-021-01543.
    >> Share

  127. VINCENT L, Gras L, Ceballos P, Finke J, et al
    Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
    Bone Marrow Transplant. 2022 Jan 10. pii: 10.1038/s41409-021-01560.
    >> Share

  128. LOSCHI M, Roux C, Sudaka I, Ferrero-Vacher C, et al
    Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
    Bone Marrow Transplant. 2022 Jan 9. pii: 10.1038/s41409-021-01544.
    >> Share

  129. EL HUSSEIN S, DiNardo CD, Takahashi K, Khoury JD, et al
    Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2022 Jan 7. pii: 10.1038/s41409-021-01538.
    >> Share

  130. ANDOLINA JR, Wang YC, Ji L, Freyer DR, et al
    Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience.
    Bone Marrow Transplant. 2022 Jan 6. pii: 10.1038/s41409-021-01558.
    >> Share

  131. STUTZ L, Halter JP, Heim D, Passweg JR, et al
    Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.
    Bone Marrow Transplant. 2022 Jan 4. pii: 10.1038/s41409-021-01546.
    >> Share

  132. VELIER M, Daumas A, Simoncini S, Arcani R, et al
    Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis.
    Bone Marrow Transplant. 2022;57:17-22.
    >> Share

    December 2021
  133. BETHGE WA, Eyrich M, Mielke S, Meisel R, et al
    Results of a multicenter phase I/II trial of TCRalphabeta and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.
    Bone Marrow Transplant. 2021 Dec 24. pii: 10.1038/s41409-021-01551.
    >> Share

    November 2021
  134. FURTADO VF, Brauneis D, Weinberg J, Elhassan N, et al
    Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis.
    Bone Marrow Transplant. 2021 Nov 29. pii: 10.1038/s41409-021-01535.
    >> Share

  135. LEAL CTS, Costa LJM, Pereira J, Duarte FB, et al
    Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
    Bone Marrow Transplant. 2021 Nov 29. pii: 10.1038/s41409-021-01531.
    >> Share

  136. IMAHASHI N, Terakura S, Kondo E, Kato K, et al
    Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies.
    Bone Marrow Transplant. 2021 Nov 24. pii: 10.1038/s41409-021-01525.
    >> Share

  137. SHUMILOV E, Shakhanova I, Flach J, Schmidt N, et al
    Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Nov 13. pii: 10.1038/s41409-021-01521.
    >> Share

  138. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2021 Nov 12. pii: 10.1038/s41409-021-01523.
    >> Share

  139. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2021 Nov 12. pii: 10.1038/s41409-021-01516.
    >> Share

  140. OTTH M, Yammine S, Usemann J, Latzin P, et al
    Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Nov 8. pii: 10.1038/s41409-021-01509.
    >> Share

  141. SCHMID C, Labopin M, Schaap N, Veelken H, et al
    Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia.
    Bone Marrow Transplant. 2021 Nov 8. pii: 10.1038/s41409-021-01515.
    >> Share

  142. ALZAHRANI M, Damlaj M, Essa M, Alahmari B, et al
    HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome.
    Bone Marrow Transplant. 2021 Nov 6. pii: 10.1038/s41409-021-01513.
    >> Share

  143. GARNICA M, Dalcolmo S, Gaio B, de Almeida AR, et al
    Pre-engraftment Cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation and its impact on engraftment.
    Bone Marrow Transplant. 2021 Nov 1. pii: 10.1038/s41409-021-01520.
    >> Share

  144. KASIKIS S, Baez J, Gandhi I, Grupp S, et al
    Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.
    Bone Marrow Transplant. 2021;56:2869-2870.
    >> Share

    October 2021
  145. MARTINO R, Garcia-Cadenas I, Esquirol A
    Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation.
    Bone Marrow Transplant. 2021 Oct 28. pii: 10.1038/s41409-021-01507.
    >> Share

  146. MIKULSKA M, Penack O, Wendel L, Knelange N, et al
    HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
    Bone Marrow Transplant. 2021 Oct 23. pii: 10.1038/s41409-021-01497.
    >> Share

  147. MARTINO M, Pitino A, Gori M, Viens P, et al
    Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study.
    Bone Marrow Transplant. 2021 Oct 23. pii: 10.1038/s41409-021-01503.
    >> Share

  148. TIEN FM, Tsai CH, Huang SC, Liu JH, et al
    Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission.
    Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01454.
    >> Share

  149. WANG X, Yu U, Yang C, Wang C, et al
    Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01499.
    >> Share

  150. SMITH PJ, Lew M, Lowder Y, Romero K, et al
    Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 19. pii: 10.1038/s41409-021-01470.
    >> Share

  151. VO P, Onstad L, Flowers ME, Storb R, et al
    Cancers after HLA-matched related bone marrow transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Oct 16. pii: 10.1038/s41409-021-01498.
    >> Share

  152. CARTER M, Taniguchi M, Yang D, Arslan S, et al
    Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Oct 11. pii: 10.1038/s41409-021-01494.
    >> Share

  153. SALVINI M, Maggi F, Damonte C, Mortara L, et al
    Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 11. pii: 10.1038/s41409-021-01487.
    >> Share

  154. KOBAYASHI S, Kanda Y, Konuma T, Inamoto Y, et al
    Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation.
    Bone Marrow Transplant. 2021 Oct 8. pii: 10.1038/s41409-021-01485.
    >> Share

  155. SELLNER L, Schetelig J, Koster L, Choi G, et al
    Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.
    Bone Marrow Transplant. 2021 Oct 7. pii: 10.1038/s41409-021-01490.
    >> Share

  156. SAVOIA C, McKeough N, Hickey B, Cochrane T, et al
    Comparison of a therapeutic platelet transfusion strategy to a prophylactic platelet transfusion strategy in autologous stem cell transplant (ASCT), a single centre experience.
    Bone Marrow Transplant. 2021 Oct 6. pii: 10.1038/s41409-021-01482.
    >> Share

  157. MILLARD T, Sammour F, Anthias C, Easdale S, et al
    Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?
    Bone Marrow Transplant. 2021 Oct 5. pii: 10.1038/s41409-021-01484.
    >> Share

  158. POIRE X, Graux C, Ory A, Herman J, et al
    Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective s
    Bone Marrow Transplant. 2021 Oct 5. pii: 10.1038/s41409-021-01464.
    >> Share

  159. PERRUCCIO K, Menconi M, Galaverna F, Pagliara D, et al
    Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses.
    Bone Marrow Transplant. 2021 Oct 4. pii: 10.1038/s41409-021-01285.
    >> Share

  160. NAKAMURA ZM, Heiling HM, Park EM, Deal AM, et al
    Impact of patient and clinical characteristics on cognitive changes after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 2. pii: 10.1038/s41409-021-01481.
    >> Share

    September 2021
  161. MAMEZ AC, Pradier A, Giannotti F, Petitpas A, et al
    Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Sep 28. pii: 10.1038/s41409-021-01466.
    >> Share

  162. PERIC Z, Peczynski C, Polge E, Kroger N, et al
    Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT.
    Bone Marrow Transplant. 2021 Sep 24. pii: 10.1038/s41409-021-01458.
    >> Share

  163. YOKOYAMA H, Hirayama M, Takahashi Y, Uchida N, et al
    Altered effect of killer immunoglobulin-like receptor-ligand mismatch by graft versus host disease prophylaxis in cord blood transplantation.
    Bone Marrow Transplant. 2021 Sep 24. pii: 10.1038/s41409-021-01469.
    >> Share

  164. RAMOS TL, Garcia-Guerrero E, Caballero-Velazquez T, Rodriguez-Gil A, et al
    Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Sep 23. pii: 10.1038/s41409-021-01452.
    >> Share

  165. ROCHA V, Arcuri LJ, Seber A, Colturato V, et al
    Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia.
    Bone Marrow Transplant. 2021 Sep 21. pii: 10.1038/s41409-021-01453.
    >> Share

  166. HOUIST AL, Bondeelle L, Salmona M, LeGoff J, et al
    Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
    Bone Marrow Transplant. 2021 Sep 21. pii: 10.1038/s41409-021-01462.
    >> Share

  167. NIE D, Zhang J, Liu L, Li X, et al
    Targeted minor histocompatibility antigen typing to estimate graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 16. pii: 10.1038/s41409-021-01459.
    >> Share

  168. SCORTECHINI I, Inglese E, Saraceni F, Poiani M, et al
    Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature.
    Bone Marrow Transplant. 2021 Sep 16. pii: 10.1038/s41409-021-01361.
    >> Share

  169. YAMAMOTO S, Kato M, Watanabe K, Ishimaru S, et al
    Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01446.
    >> Share

  170. ABUELGASIM KA, Damlaj M, Bosaeed M, Altamimi S, et al
    Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01457.
    >> Share

  171. PINCEZ T, Santiago R, Bittencourt H, Louis I, et al
    Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children.
    Bone Marrow Transplant. 2021 Sep 2. pii: 10.1038/s41409-021-01408.
    >> Share

    August 2021
  172. DIAZ-DE-HEREDIA C, Bresters D, Faulkner L, Yesilipek A, et al
    Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.
    Bone Marrow Transplant. 2021 Aug 31. pii: 10.1038/s41409-021-01449.
    >> Share

  173. AKDOGAN N, Ersoy-Evans S, Visal Okur F, Kuskonmaz B, et al
    Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Aug 27. pii: 10.1038/s41409-021-01441.
    >> Share

  174. MALLADI R, Ahmed I, McIlroy G, Dignan FL, et al
    Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial.
    Bone Marrow Transplant. 2021 Aug 26. pii: 10.1038/s41409-021-01439.
    >> Share

  175. XU LP, Lu PH, Wu DP, Sun ZM, et al
    Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01431.
    >> Share

  176. GOKLEMEZ S, Saligan LN, Pirsl F, Holtzman NG, et al
    Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01419.
    >> Share

  177. SNARSKI E, Stringer J, Mikulska M, Gil L, et al
    Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of
    Bone Marrow Transplant. 2021 Aug 21. pii: 10.1038/s41409-021-01430.
    >> Share

  178. JANSSEN MJM, Bruns AHW, Verduyn Lunel FM, Raijmakers RAP, et al
    Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 20. pii: 10.1038/s41409-021-01437.
    >> Share

  179. MODEMANN F, Ayuk F, Wolschke C, Christopeit M, et al
    Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01425.
    >> Share

  180. WOLFF D, Herzberg PY, Herrmann A, Pavletic SZ, et al
    Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of H
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01404.
    >> Share

  181. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01405.
    >> Share

  182. GRANELL M, Senin A, Barata A, Cibeira MT, et al
    Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2021 Aug 17. pii: 10.1038/s41409-021-01429.
    >> Share

  183. JAYANI RV, Olin RL
    Physically "fit" for allogeneic stem cell transplant?
    Bone Marrow Transplant. 2021 Aug 16. pii: 10.1038/s41409-021-01436.
    >> Share

  184. TAMAI H, Tajika K, Nakayama K, Arai A, et al
    Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide.
    Bone Marrow Transplant. 2021 Aug 12. pii: 10.1038/s41409-021-01432.
    >> Share

  185. MISHRA A, Pidala J, Thapa R, Betts BC, et al
    Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01428.
    >> Share

  186. OHMOTO A, Fuji S
    Cardiac complications associated with hematopoietic stem-cell transplantation.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01427.
    >> Share

  187. WU Y, Zhao Y, Wang T, Xia J, et al
    Evaluation of diagnostic performance of metagenomic next-generation sequencing when applied in patients after allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2021 Aug 10. pii: 10.1038/s41409-021-01423.
    >> Share

  188. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Aug 9. pii: 10.1038/s41409-021-01421.
    >> Share

  189. CORNILLON J, Daguenet E, Tournilhac O, Blaise D, et al
    Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire.
    Bone Marrow Transplant. 2021 Aug 6. pii: 10.1038/s41409-021-01426.
    >> Share

    July 2021
  190. NIEDERWIESER C, Morozova E, Zubarovskaya L, Zabelina T, et al
    Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
    Bone Marrow Transplant. 2021 Jul 30. pii: 10.1038/s41409-021-01410.
    >> Share

  191. LEW TE, Cliff ERS, Dickinson M, Tam CS, et al
    T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.
    Bone Marrow Transplant. 2021 Jul 20. pii: 10.1038/s41409-021-01418.
    >> Share

  192. KANG HM, Kim SK, Ryu IH, Lee JW, et al
    Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
    >> Share

  193. ZUCENKA A, Vaitekenaite V, Maneikis K, Davainis L, et al
    Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01416.
    >> Share

  194. ABO S, Ritchie D, Denehy L, Panek-Hudson Y, et al
    Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study.
    Bone Marrow Transplant. 2021 Jul 16. pii: 10.1038/s41409-021-01411.
    >> Share

  195. JENTZSCH M, Grimm J, Bill M, Kupper J, et al
    Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01407.
    >> Share

  196. KONDO G, Ishimaru F, Konuma T, Takahashi S, et al
    Cord blood index predicts engraftment and early non-relapse mortality in adult patients with single-unit cord blood transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01406.
    >> Share

  197. CUVELIER S, Blaise D, Boher JM, Villaron-Goetgheluck C, et al
    A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 14. pii: 10.1038/s41409-021-01401.
    >> Share

  198. LUFT T, Dreger P, Radujkovic A
    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01390.
    >> Share

  199. ALARCON TOMAS A, Whiting K, Maloy M, Ruiz JD, et al
    The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01392.
    >> Share

  200. BORTNICK R, Wlodarski M, de Haas V, De Moerloose B, et al
    Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Jul 9. pii: 10.1038/s41409-021-01374.
    >> Share

  201. TANG FF, Zhao XY, Huo MR, Chang YJ, et al
    Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.
    Bone Marrow Transplant. 2021 Jul 8. pii: 10.1038/s41409-021-01382.
    >> Share

  202. COSTA TCM, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, et al
    Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01365.
    >> Share

  203. LANKESTER AC, Albert MH, Booth C, Gennery AR, et al
    EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01378.
    >> Share

  204. BAA AK, Chellapuram SK, Sharma A, Malik PS, et al
    Poems syndrome: consolidation with autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01395.
    >> Share

  205. PRYCE A, Mir F, Ushiro-Lumb I, Drypen R, et al
    SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01379.
    >> Share

  206. LIU L, Miao M, Chen X, Zhang Y, et al
    Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01398.
    >> Share

  207. WOLFF D, Fatobene G, Rocha V, Kroger N, et al
    Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01389.
    >> Share

  208. ANSARI M, Petrykey K, Rezgui MA, Del Vecchio V, et al
    Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT.
    Bone Marrow Transplant. 2021 Jul 2. pii: 10.1038/s41409-021-01386.
    >> Share

  209. LUCIA A, Fiuza-Luces C
    Physical fitness and childhood hematopoietic stem cell transplantation: a call to action.
    Bone Marrow Transplant. 2021 Jul 1. pii: 10.1038/s41409-021-01397.
    >> Share

    June 2021
  210. LUPO-STANGHELLINI MT, Xue E, Mastaglio S, Oltolini C, et al
    COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
    Bone Marrow Transplant. 2021 Jun 30. pii: 10.1038/s41409-021-01278.
    >> Share

  211. LEMIEUX C, Muffly LS, Iberri DJ, Craig JK, et al
    Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
    Bone Marrow Transplant. 2021 Jun 23. pii: 10.1038/s41409-021-01371.
    >> Share

  212. GILFANOVA R, Callegari A, Childs A, Yang G, et al
    A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01368.
    >> Share

  213. FRIDH MK, Simonsen C, Schmidt-Andersen P, Nissen AA, et al
    Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01370.
    >> Share

  214. BERGERON A
    Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions!
    Bone Marrow Transplant. 2021 Jun 18. pii: 10.1038/s41409-021-01381.
    >> Share

  215. FERNANDEZ-SOJO J, Azqueta C, Valdivia E, Martorell L, et al
    Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
    Bone Marrow Transplant. 2021 Jun 14. pii: 10.1038/s41409-021-01367.
    >> Share

  216. BONIFAZI F, Defrancesco I, Olivieri J, Barbato F, et al
    Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01359.
    >> Share

  217. FLOISAND Y, Schroeder MA, Chevallier P, Selleslag D, et al
    A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01356.
    >> Share

  218. KAWASHIMA N, Nishikawa E, Tsuchisaka A, Hashimoto T, et al
    Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01335.
    >> Share

    May 2021
  219. ESQUIROL A, Pascual MJ, Kwon M, Perez A, et al
    Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01328.
    >> Share

  220. WAIDHAUSER J, Labopin M, Esteve J, Kroger N, et al
    Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01322.
    >> Share

  221. KUMARI R, Palaniyandi S, Hildebrandt GC
    The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease.
    Bone Marrow Transplant. 2021 May 29. pii: 10.1038/s41409-021-01325.
    >> Share

  222. SUN X, Yang J, Cai Y, Wan L, et al
    Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation
    Bone Marrow Transplant. 2021 May 25. pii: 10.1038/s41409-021-01358.
    >> Share

  223. GRECO R, Alexander T, Burman J, Del Papa N, et al
    Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01326.
    >> Share

  224. LACY M, Fong M, Bolton C, Maranzano M, et al
    Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01331.
    >> Share

  225. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
    T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
    >> Share

  226. MIKULSKA M, Tridello G, Hoek J, Gil L, et al
    Legionellosis after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 22. pii: 10.1038/s41409-021-01333.
    >> Share

  227. BEAUVERD Y, Morin S, Stephan C, De Ramon Ortiz C, et al
    The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
    Bone Marrow Transplant. 2021 May 18. pii: 10.1038/s41409-021-01334.
    >> Share

  228. SHIMOMURA Y, Hara M, Konuma T, Itonaga H, et al
    Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients.
    Bone Marrow Transplant. 2021 May 15. pii: 10.1038/s41409-021-01324.
    >> Share

  229. SEO S, Usui Y, Matsuo K, Atsuta Y, et al
    Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2021 May 14. pii: 10.1038/s41409-021-01289.
    >> Share

  230. VIJENTHIRA A, Kuruvilla J, Prica A
    Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01327.
    >> Share

  231. XU L, Feng J, Xu X, Li X, et al
    IL-17-producing gammadeltaT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1(+)CD11b(+) myeloid-derived suppressor cells.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01299.
    >> Share

  232. MURATA M, Terakura S, Wake A, Miyao K, et al
    Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence.
    Bone Marrow Transplant. 2021 May 11. pii: 10.1038/s41409-021-01304.
    >> Share

  233. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 10. pii: 10.1038/s41409-021-01315.
    >> Share

  234. ALBERT MH, Sirin M, Hoenig M, Hauck F, et al
    Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
    Bone Marrow Transplant. 2021 May 9. pii: 10.1038/s41409-021-01323.
    >> Share

  235. DE OLIVEIRA RODRIGUES M, de Almeida Testa LH, Dos Santos ACF, Zanetti LP, et al
    Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 8. pii: 10.1038/s41409-021-01329.
    >> Share

  236. SHIRATORI S, Sugita J, Fuji S, Aoki J, et al
    Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01314.
    >> Share

  237. DERENZINI E, Tabanelli V, Sammassimo S, Mazzara S, et al
    Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01320.
    >> Share

  238. FRIEDMAN D, Dozor AJ, Milner J, D'Souza M, et al
    Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2021 May 6. pii: 10.1038/s41409-021-01298.
    >> Share

  239. KALOYANNIDIS P, Ayyad A, Bahaliwah Z, Blowi B, et al
    Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01318.
    >> Share

  240. DE LA PUERTA R, Montoro J, Aznar C, Lorenzo I, et al
    Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01319.
    >> Share

  241. OOSTENBRINK LVE, Pool ES, Jol-van der Zijde CM, Jansen-Hoogendijk AM, et al
    Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 3. pii: 10.1038/s41409-021-01302.
    >> Share

    April 2021
  242. TOYODA K, Yasunaga JI, Choi I, Suehiro Y, et al
    The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01311.
    >> Share

  243. HARADA K, Kimura SI, Fuji S, Najima Y, et al
    Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01310.
    >> Share

  244. SAITO Y, Urashima M, Takahashi Y, Ogawa A, et al
    Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01303.
    >> Share

  245. BURT RK, Muraro PA, Farge D, Oliveira MC, et al
    New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01277.
    >> Share

  246. RAGON BK
    FLT3-ITDos and FLT3-ITDon'ts: navigating maintenance therapy in FLT3-ITD-positive acute myeloid leukemia following stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01269.
    >> Share

  247. AMONOO HL, El-Jawahri A, Celano CM, Brown LA, et al
    A positive psychology intervention to promote health outcomes in hematopoietic stem cell transplantation: the PATH proof-of-concept trial.
    Bone Marrow Transplant. 2021 Apr 20. pii: 10.1038/s41409-021-01296.
    >> Share

  248. INOUE Y, Okinaka K, Fuji S, Inamoto Y, et al
    Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01291.
    >> Share

  249. FIALA MA, King J, Feinberg D, Goldsmith SR, et al
    Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01295.
    >> Share

  250. RUSSO D, Polverelli N, Malagola M, Farina M, et al
    Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01287.
    >> Share

  251. EYRE TA, Caillard S, Finel H, Boumendil A, et al
    Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2021 Apr 16. pii: 10.1038/s41409-021-01270.
    >> Share

  252. RAMDIAL JL, Mehta RS, Saliba RM, Alousi AM, et al
    Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01274.
    >> Share

  253. WU J, Fu HX, He Y, Mo XD, et al
    Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01293.
    >> Share

  254. EGLSEER D, Bauer S, Huber-Krassnitzer B, Greinix H, et al
    Malnutrition risk prior to hematopoietic stem cell transplantation predicts mortality in adults.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01292.
    >> Share

  255. NELSON AM, Johnson PC, Kavanaugh AR, Jackson VA, et al
    Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01281.
    >> Share

  256. BADAR T, Szabo A, Litzow M, Burkart M, et al
    Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01279.
    >> Share

  257. LIU W, Fan Z, Zhang Y, Huang F, et al
    Metagenomic next-generation sequencing for identifying pathogens in central nervous system complications after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01243.
    >> Share

  258. HAGHIRI S, Fayech C, Mansouri I, Dufour C, et al
    Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01258.
    >> Share

  259. STATHOPOULOS P, Leger K, Foege M, Lutterotti A, et al
    Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01276.
    >> Share

    March 2021
  260. DAHER-REYES G, Kim T, Novitzky-Basso I, Kim KH, et al
    Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01255.
    >> Share

  261. BENTO L, Gutierrez A, Novelli S, Montoro J, et al
    Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01264.
    >> Share

  262. LAZZARO C, Castagna L, Lanza F, Laszlo D, et al
    Chemotherapy-based versus chemotherapy-free stem cell mobilization (+/- plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis.
    Bone Marrow Transplant. 2021 Mar 22. pii: 10.1038/s41409-021-01251.
    >> Share

  263. IMOTO H, Yoshioka S, Hiramoto N, Morita-Fujita M, et al
    Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.
    Bone Marrow Transplant. 2021 Mar 10. pii: 10.1038/s41409-021-01263.
    >> Share

  264. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01254.
    >> Share

  265. KONISHI T, Kusakabe S, Hino A, Inamoto K, et al
    Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01249.
    >> Share

  266. KAPOOR J, Khushoo V, Garg A, Naim F, et al
    An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01256.
    >> Share

  267. SHAH RM
    Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01246.
    >> Share

  268. RUGGERI A, Labopin M, Angelucci E, Blaise D, et al
    Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01248.
    >> Share

  269. RITACCO C, Ehx G, Gregoire C, Daulne C, et al
    High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 4. pii: 10.1038/s41409-021-01221.
    >> Share

  270. REUSING SB, Manser AR, Groeneveld-Krentz S, Rebmann V, et al
    HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01231.
    >> Share

  271. ELMARIAH H, Naqvi SMH, Kim J, Nishihori T, et al
    Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01219.
    >> Share

  272. SHIMOMURA Y, Hara M, Yamamoto H, Uchida N, et al
    Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01217.
    >> Share

  273. PULIAFITO B, Zhao Y, Afshar S, Galitzeck Z, et al
    Comparison of post-transplant vaccination among allogeneic and autologous hematopoietic stem cell transplant patients: a single center quality analysis.
    Bone Marrow Transplant. 2021 Mar 1. pii: 10.1038/s41409-021-01240.
    >> Share

    February 2021
  274. TANG X, Valdez BC, Ma Y, Zhang Q, et al
    Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01238.
    >> Share

  275. MISKIEWICZ-BUJNA J, Miskiewicz-Migon I, Panasiuk A, Kubica-Cielinska A, et al
    Severe and fatal toxicity after hematopoietic stem cell transplantation in GNE defect-associated thrombocytopenia.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01235.
    >> Share

  276. LAI X, Liu L, Zhang Z, Shi L, et al
    Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Bone Marrow Transplant. 2021 Feb 19. pii: 10.1038/s41409-021-01233.
    >> Share

  277. CHRISTOPEIT M, Reichard M, Niederwieser C, Massoud R, et al
    Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01225.
    >> Share

  278. SHEIKH MA, Im A, Ballen K, Hashmi SK, et al
    Association of graft-versus-host-disease with neurologic complications: clinical paradigm and future directions.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01216.
    >> Share

  279. PAUTAS C, Raffoux E, Lambert J, Legrand O, et al
    Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-020-01207.
    >> Share

  280. RUBEN CL, Pirsl F, Steinberg SM, Holtzman NG, et al
    Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-021-01211.
    >> Share

  281. PRINCE HM, Abeyakoon C
    Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sezary syndrome: never-late, never-never?
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-020-01150.
    >> Share

    January 2021
  282. DAI H, Penack O, Radujkovic A, Schult D, et al
    Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
    Bone Marrow Transplant. 2021 Jan 30. pii: 10.1038/s41409-020-01186.
    >> Share

  283. AHMED N, Li L, Rojas P, Covut F, et al
    Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01223.
    >> Share

  284. SAKURAI M, Mori T, Kato K, Kanaya M, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01192.
    >> Share

  285. CESARO S, Tridello G, Knelange NS, Blijlevens N, et al
    Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01212.
    >> Share

  286. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01200.
    >> Share

  287. LOPEZ R, Plat G, Bertrand Y, Ducassou S, et al
    Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study.
    Bone Marrow Transplant. 2021 Jan 16. pii: 10.1038/s41409-020-01180.
    >> Share

  288. VAN LEEUWEN SJM, Proctor GB, Laheij AMGA, Potting CMJ, et al
    Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01185.
    >> Share

  289. WEI N, Wang Y, Wang J, Wu L, et al
    Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01193.
    >> Share

  290. DOMINGO-DOMENECH E, Duarte RF, Boumedil A, Onida F, et al
    Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sezary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01197.
    >> Share

  291. WALLACE G, Khandelwal P, Myers KC, Perentesis EMR, et al
    Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01189.
    >> Share

  292. OKOEV G, Weisdorf DJ, Wagner JE, Blazar BR, et al
    Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01195.
    >> Share

  293. SUN X, Su Y, Liu X, Zhang Y, et al
    Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models.
    Bone Marrow Transplant. 2021 Jan 7. pii: 10.1038/s41409-020-01187.
    >> Share

    December 2020
  294. GIAMMARCO S, Raiola AM, Di Grazia C, Bregante S, et al
    Second haploidentical stem cell transplantation for primary graft failure.
    Bone Marrow Transplant. 2020 Dec 16. pii: 10.1038/s41409-020-01183.
    >> Share

  295. XU ZL, Huang XJ
    Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01169.
    >> Share

  296. SANZ J, Labopin M, Sanz MA, Aljurf M, et al
    Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01162.
    >> Share

  297. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
    Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
    >> Share

  298. MORI T, Kikuchi T, Koh M, Koda Y, et al
    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
    >> Share

  299. MONTORO J, Chorao P, Bento L, Cabrero M, et al
    Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01161.
    >> Share

  300. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    >> Share

  301. HIRSCHBUHL K, Labopin M, Houhou M, Gabellier L, et al
    Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2020 Dec 9. pii: 10.1038/s41409-020-01173.
    >> Share

  302. MAZIARZ RT, Levis M, Patnaik MM, Scott BL, et al
    Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
    Bone Marrow Transplant. 2020 Dec 7. pii: 10.1038/s41409-020-01153.
    >> Share

  303. BAKER LX, Chen F, Ssempijja Y, Byrne M, et al
    Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Dec 5. pii: 10.1038/s41409-020-01158.
    >> Share

  304. SONG GY, Yoon DH, Suh C, Moon JH, et al
    Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01160.
    >> Share

  305. BAI B, Wang XX, Gao Y, Li PF, et al
    Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01164.
    >> Share

  306. VAXMAN I, Visram A, Kumar S, Dispenzieri A, et al
    Autologous stem cell transplantation for multiple myeloma patients aged >/= 75 treated with novel agents.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01159.
    >> Share

  307. JABBOUR J, Manana B, Zahreddine A, Al-Shaar L, et al
    Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial.
    Bone Marrow Transplant. 2020 Dec 1. pii: 10.1038/s41409-020-01154.
    >> Share

    November 2020
  308. BERRO M, Rivas M, Trucco J, Paganini I, et al
    Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center exper
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01146.
    >> Share

  309. PAVIGLIANITI A, Labopin M, Blaise D, Socie G, et al
    Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01155.
    >> Share

  310. OTTH M, Schindera C, Gungor T, Ansari M, et al
    Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study.
    Bone Marrow Transplant. 2020 Nov 25. pii: 10.1038/s41409-020-01137.
    >> Share

  311. HUA J, Zhang J, Zhang X, Wu X, et al
    Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 24. pii: 10.1038/s41409-020-01140.
    >> Share

  312. EBBESEN M, Weischendorff S, Kielsen K, Kammersgaard M, et al
    Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01127.
    >> Share

  313. MENGLING T, Rall G, Bernas SN, Astreou N, et al
    Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01138.
    >> Share

  314. JENTZSCH M, Grimm J, Bill M, Brauer D, et al
    ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 19. pii: 10.1038/s41409-020-01129.
    >> Share

  315. VAXMAN I, Sidiqi MH, Al Saleh AS, Kumar S, et al
    Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.
    Bone Marrow Transplant. 2020 Nov 18. pii: 10.1038/s41409-020-01136.
    >> Share

  316. BLAGOV S, Zvyagin IV, Shelikhova L, Khismatullina R, et al
    T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after alphabeta T cell-depleted hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01128.
    >> Share

  317. MAAS-BAUER K, Kiote-Schmidt C, Bertz H, Apostolova P, et al
    Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01122.
    >> Share

  318. KANG HM, Kim SK, Lee JW, Chung NG, et al
    Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01121.
    >> Share

  319. CASTAGNA L, Pagliardini T, Bramanti S, Schiano de Colella JM, et al
    Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
    Bone Marrow Transplant. 2020 Nov 15. pii: 10.1038/s41409-020-01133.
    >> Share

  320. MARCO-AYALA J, Gomez-Segui I, Sanz G, Solves P, et al
    Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
    Bone Marrow Transplant. 2020 Nov 14. pii: 10.1038/s41409-020-01124.
    >> Share

  321. KHAN M, Iftikhar R, Ghafoor T, Hussain F, et al
    Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan.
    Bone Marrow Transplant. 2020 Nov 12. pii: 10.1038/s41409-020-01126.
    >> Share

  322. GERTZ MA, Lacy MQ, Jacob EK, Hogan WJ, et al
    Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2020 Nov 11. pii: 10.1038/s41409-020-01131.
    >> Share

  323. SULTAN AM, Mahmoud HK, Fathy GM, Abdelfattah NM, et al
    The outcome of hematopoietic stem cell transplantation patients with COVID-19 infection.
    Bone Marrow Transplant. 2020 Nov 4. pii: 10.1038/s41409-020-01094.
    >> Share

  324. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress.
    Bone Marrow Transplant. 2020 Nov 3. pii: 10.1038/s41409-020-01098.
    >> Share

  325. MORITA K, Fujiwara SI, Ikeda T, Kawaguchi SI, et al
    Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01096.
    >> Share

    October 2020
  326. IWAMOTO M, Ikegawa S, Kondo T, Meguri Y, et al
    Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01100.
    >> Share

  327. YOON JH, Min GJ, Park SS, Park S, et al
    Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01097.
    >> Share

  328. IRENE GC, Albert E, Anna BV, Rahinatu A, et al
    Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching.
    Bone Marrow Transplant. 2020 Oct 26. pii: 10.1038/s41409-020-01092.
    >> Share

  329. EL-SERAFI A, He R, Zheng W, Benkossou F, et al
    Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.
    Bone Marrow Transplant. 2020 Oct 21. pii: 10.1038/s41409-020-01091.
    >> Share

  330. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 20. pii: 10.1038/s41409-020-01090.
    >> Share

  331. MODI D, Kim S, Deol A, Ayash L, et al
    Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Oct 16. pii: 10.1038/s41409-020-01079.
    >> Share

  332. BENTO L, Boumendil A, Finel H, Khvedelidze I, et al
    Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01075.
    >> Share

  333. KEKRE N, Kim HT, Hofer J, Ho VT, et al
    Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01083.
    >> Share

  334. MORISHIMA S, Fukuda T, Doki N, Mori T, et al
    Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
    Bone Marrow Transplant. 2020 Oct 9. pii: 10.1038/s41409-020-01070.
    >> Share

  335. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2020 Oct 7. pii: 10.1038/s41409-020-01053.
    >> Share

  336. LOKE J, Labopin M, Craddock C, Niederwieser D, et al
    Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01072.
    >> Share

  337. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01069.
    >> Share

    September 2020
  338. SUGITA J, Kamimura T, Ishikawa T, Ota S, et al
    Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Sep 24. pii: 10.1038/s41409-020-01065.
    >> Share

  339. MAAKARON JE, McKenna D Jr, El-Jurdi N, Arora M, et al
    COVID19 seroconversion in an unrelated stem cell donor.
    Bone Marrow Transplant. 2020 Sep 22. pii: 10.1038/s41409-020-01066.
    >> Share

  340. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01056.
    >> Share

  341. SALEH W, Katz J
    Periodontal diseases, caries, and dental abscesses prevalence in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01057.
    >> Share

    May 2020
  342. OLRY DE LABRY LIMA A, Matas Hoces A, Gimeno Ballester V, Rios Sanchez E, et al
    Cost-effectiveness of lenalidomide.
    Bone Marrow Transplant. 2020;55:853-854.
    >> Share

  343. DHANASIRI S
    Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells.
    Bone Marrow Transplant. 2020;55:987-988.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016